Last updated: February 21, 2024
Sponsor: University of Washington
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pain (Pediatric)
Multiple Sclerosis
Memory Loss
Treatment
ExerciseRx intervention
Clinical Study ID
NCT06270641
STUDY00018628
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Provider-confirmed diagnosis of MS using revised 2017 McDonald criteria
- > 18+ years of age
- Patient determined disease steps (PDDS) score < 3, indicating the potential for somegait disability although typically ambulates without an assistive device
- Insufficiently active, defined as < 150 minutes of physical activity per week,assessed using the PAVS in the EHR in clinics as part of the routine patient intakeprocess
- Use of an iPhone with software version iOS13+ or an Android phone 4.1+
- Agree to install and use the ExerciseRx app for the entire study period and keep theirphone on them during the daytime (e.g., pocket, bags, hands)
Exclusion
Exclusion Criteria:
- Recent (past 4 weeks) or planned surgery during the study period which may impactengaging in step counts
- MS relapse within the last 30 days
- Plans to travel internationally during the study period, which could interfere withserver uploads of mobile phone data
- Those at a higher risk of falling or injury from falls or unable to safely exercisedue to other medical conditions (e.g. heart conditions, diabetes or conditions madeworse by walking or physical activity)
Study Design
Total Participants: 106
Treatment Group(s): 1
Primary Treatment: ExerciseRx intervention
Phase:
Study Start date:
February 16, 2024
Estimated Completion Date:
September 30, 2026
Study Description
Connect with a study center
UW Medicine
Seattle, Washington 98133
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.